[ET Net News Agency, 15 July 2026] DUALITYBIO-B (09606) rose 10.4% to HK$246.
It hits an intra-day high of HK$246, hitting an 1-month high, and an intra-day low of HK$222.6. The total shares traded was 1.03 million, with a value of HK$245.42m. The active buy/sell ratio is 67:33, with net buying turnover of HK$76.66m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$7.05m, with volume weighted average price of HK$238.44. BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$13.56m, with volume weighted average price of HK$239.414. The stock has risen a combined 13.5% over the past 2 consecutive trading days.
Basic Information| Nominal | 246.000 | % Chg | +10.41% |
| High | 246.000 | Low | 222.600 |
| Shares Tr | 1.03m | Turnover | 245.42m |
| 10-D SMA | 218.420 | %H.V | 92.337 |
| 20-D SMA | 198.000 | VWAP | 238.151 |
| 50-D SMA | 211.104 | RSI14 | 65.194 |
Status: Hitting an 1-month high, active buy/sell ratio is 67:33, with net buying turnover of HK$76.66m, rising a combined 13.5% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| DUALITYBIO-B (09606) | 246.00 | +10.41 |
| INNOVENT BIO (01801) | 97.90 | +8.72 |
| WUXI BIO (02269) | 39.98 | +4.66 |
| WUXI APPTEC (02359) | 166.70 | +5.44 |
| PHARMARON (03759) | 25.82 | +9.41 |
| JOINN (06127) | 26.24 | +18.20 |
| BEONE MEDICINES (06160) | 191.70 | +3.18 |
| SKB BIO (06990) | 554.50 | +11.30 |
| AKESO (09926) | 104.70 | +9.23 |
| REMEGEN (09995) | 87.75 | +6.36 |
(ed)
Nominal 
